Hi Dan,
Since I noticed you talking about Directors what is the point of having David Austin Alternate Director of QBL/CGB when he only attended 1 of 8 board meetings according to the 2018 Annual report, and how is he beneficial to Shareholders if he doesn't attend meetings?
https://www.asx.com.au/asxpdf/20180629/pdf/43w52vnpdcbs6w.pdf
Cheers
Medcann separate listing., page-23
-
- There are more pages in this discussion • 33 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)